En 15 måneder gammel jente med feber og pancytopeni

Tidsskrift for den Norske Laegeforening

Volumn 131, Issue 24, 2011, Pages 2482-2486

  Skram, Marius Kurås ^a,c   Bjering, Sidsel ^a   Hermansen, Nils Olav ^b   Dini, Leigh ^a   Hellebostad, Marit ^a,b,d  

^a Barnemedisinsk avdeling ^*  (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c Barneavdelingen   (Norway)

^d OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B; ANTIPROTOZOAL AGENT;

ARTICLE; BONE MARROW; CASE REPORT; DIFFERENTIAL DIAGNOSIS; FEMALE; FEVER; HEMOPHAGOCYTIC LYMPHOHISTIOCYTOSIS; HUMAN; INFANT; INSECT BITE; PANCYTOPENIA; PATHOLOGY; SOUTHERN EUROPE; TRAVEL; VISCERAL LEISHMANIASIS;

AMPHOTERICIN B; ANTIPROTOZOAL AGENTS; BONE MARROW; DIAGNOSIS, DIFFERENTIAL; FEMALE; FEVER; HUMANS; INFANT; INSECT BITES AND STINGS; LEISHMANIASIS, VISCERAL; LYMPHOHISTIOCYTOSIS, HEMOPHAGOCYTIC; MEDITERRANEAN REGION; PANCYTOPENIA; TRAVEL;

EID: 84856167638     PISSN: 00292001     EISSN: 08077096     Source Type: Journal    
DOI: 10.4045/tidsskr.11.0387     Document Type: Article

References (17)

1. Henter J-I, Horne AC, Aricó M et al. HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2007; 48: 124-31.
2. Janka GE. Familial and acquired hemophagocytic lymphohistiocytosis. Eur J Pediatr 2007; 166: 95-109.
3. Gupta S, Weitzman S. Primary and secondary hemophagocytic lymphohistiocytosis: clinical features, pathogenesis and therapy. Expert Rev Clin Immunol 2010; 6: 137-54.
4. Ready PD. Leishmaniasis emergence in Europe. Euro Surveill 2010; 15: 19505. www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19505 (16.6.2011).
5. Meyerhoff A. U.S. Food and Drug Administration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis. Clin Infect Dis 1999; 28: 42-8.
6. Bern C. Treatment of visceral leishmaniasis. UpToDate versjon 19.1. 2011 www.uptodate.com/contents/treatment-of-visceral-leishmaniasis (28.8.2010).
7. Schönian G, Nasereddin A, Dinse N et al. PCR diagnosis and characterization of Leishmania in local and imported clinical samples. Diagn Microbiol Infect Dis 2003; 47: 349-58.
8. Allen CE, Yu X, Kozinetz CA et al. Highly elevated ferritin levels and the diagnosis of hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer 2008; 50: 1227-35.
9. Horne AC, Janka G, Maarten Egeler R et al. Haematopoietic stem cell transplantation in haemophagocytic lymphohistiocytosis. Br J Haematol 2005; 129: 622-30.
10. Meeths M, Entesarian M, Al-Herz W et al. Spectrum of clinical presentations in familial hemophagocytic lymphohistiocytosis type 5 patients with mutations in STXBP2. Blood 2010; 116: 2635-43.
11. Ishii E, Ohga S, Imashuku S et al. Nationwide survey of hemophagocytic lymphohistiocytosis in Japan. Int J Hematol 2007; 86: 58-65.
12. Gagnaire MH, Galambrun C, Stéphan JL. Hemophagocytic syndrome: a misleading complication of visceral leishmaniasis in children-a series of 12 cases. Pediatrics 2000; 106: E58.
13. Bern C. Clinical manifestations and diagnosis of visceral leishmaniasis. www.uptodate.com/contents/clinical-manifestations-and-diagnosisof-visceral-leishmaniasis (28.8.2010).
14. Palumbo E. Visceral leishmaniasis in children: a review. Minerva Pediatr 2010; 62: 389-95.
15. Mondal S, Bhattacharya P, Ali N. Current diagnosis and treatment of visceral leishmaniasis. Expert Rev Anti Infect Ther 2010; 8: 919-44.
16. The global burden of disease: WHO 2004 Update. www.who.int/healthinfo/global_burden_disease/2004_report_update/en/index.html (26.2.2011).
17. Rajagopala S, Dutta U, Chandra KSP et al. Visceral leishmaniasis associated hemophagocytic lymphohistiocytosis- case report and systematic review. J Infect 2008; 56: 381-8.